Skip to main content
 

AHA Innovators’ Network Member Biobeat’s RPM Devices and Platform Receive FDA Clearances for Stroke Volume and Cardiac Output

AHA Innovators’ Network Member Biobeat’s RPM Devices and Platform Receive FDA Clearances for Stroke Volume and Cardiac Output

Innovators’ Network member company Biobeat, announced that its wearable remote patient monitoring devices have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to monitor stroke volume and cardiac output in addition to cuffless blood pressure, blood oxygen saturation, pulse rate, respiratory rate and body temperature.  Read more here.

More News

  • WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

  • Noah Labs Obtains FDA Breakthrough Device Designation for its AI-Powered Voice Diagnostic for Heart Failure

  • Tabia Health Announces Its AI-Powered Care Orchestration Platform is Now a Qualified Solution on Mayo Clinic Platform, Enabling Care Workflow Transformation.